【24h】

Risk of ocular complications following radiation therapy in patients with nasopharyngeal carcinoma

机译:鼻咽癌患者放射治疗后眼部并发症的风险

获取原文
获取原文并翻译 | 示例
       

摘要

Objective To examine the risk of ocular complications following radiotherapy in patients with nasopharyngeal carcinoma (NPC). Methods We adopted 1:1 propensity score matching and identified an NPC cohort (n = 736) and a comparison cohort (n = 736) that comprised non‐NPC head and neck cancer patients who received radiotherapy in the National Health Insurance Research Database from 1997 to 2010. The follow‐up period was terminated upon developing ocular complications (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD‐9‐CM]360‐379) or on December 31, 2010. Results After adjusting for the confounding factors of the study, the NPC cohort had a higher adjusted hazard ratio (HR) for developing ocular complications than the comparison cohort (adjusted HR = 2.786, 95% confidence interval [CI] =?1.805–4.112, P ?0.001). The NPC cohort was associated with a significantly higher risk of developing ocular complications compared with the comparison cohort within 12 and after 24 months of follow‐up ( P ?0.05). The most common associated ocular complications were optic nerve disorder and retinopathy. Conclusions Patients with NPC might be at higher risk of developing ocular complications after radiotherapy than non‐NPC head and neck cancer patients in Taiwan. Either further investigation or routine assessments by ophthalmological physician is recommended. Level of Evidence NA Laryngoscope , 130:1270–1277, 2020
机译:目的探讨鼻咽癌(NPC)患者放疗后眼部并发症的风险。方法采用1:1倾向得分匹配,并确定了NPC队列(n = 736)和一个组成的非NPC头部和颈部癌症患者,其1997年从国家健康保险研究数据库中获得放射治疗的非NPC头部和颈部癌症患者的比较队列(n = 736)到2010年。随访期终止了发育眼部并发症(国际疾病分类,第九次修订,临床修改[ICD-9-CM]或2010年12月31日)。调整混杂因素后的结果在该研究中,NPC队列具有更高的调节危险比(HR),用于开发比较队列的眼部并发症(调节的HR = 2.786,95%置信区间[CI] =?1.805-4.112,P& 0.001)。与12个月后的比较队列相比,NPC队列与发育眼部并发症的风险显着更高,随访后24个月(P <0.05)。最常见的相关眼部并发症是视神经病症和视网膜病变。结论患有NPC的患者可能在放射治疗后发育眼部并发症的风险更高,而不是台湾的非NPC头部和颈部癌症患者。建议使用眼科医生进一步调查或常规评估。证据水平na喉镜,130:1270-1277,2020

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号